Cellectis S.A. (CMVLF)
OTC
Real-time Data
01:30 PM
Day's Range
3.4752 wk Range
2.60Overview - CMVLF - Cellectis S.A.
Key Statistics
Valuation
Enterprise Value
165.92M
P/E (Trailing)
‪-5.17‬
Price / Sales (TTM)
‪7.10‬
Price / Book
‪7.96‬
EV / EBITDA
‪-3.55‬
Profitability
Gross Margin
‪54.96%‬
Profit Margin
‪-102.33%‬
Operating Margin
‪-340.68%‬
Return on Assets
‪-11.66%‬
Return on Equity
‪-94.53%‬
Ownership
Shares Outstanding
100.69M
Float
46.78M
Held by Insiders
‪48.00%‬
Held by Institutions
‪10.42%‬
Price stats
Beta
‪2.75‬
50-Day Avg
‪3.47‬
200-Day Avg
‪3.89‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - CMVLF - Cellectis S.A.
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
- CMVLFOTCCellectis S.A.349.42MMarket Cap+25.65%52-week change-5.18P/E (Trailing)‪-89.50%‬Profit Margin
- ARGNFOTCargenx SE61.87BMarket Cap+31.34%52-week change37.88P/E (Trailing)‪32.26%‬Profit Margin
- BEIGFOTCBeiGene Ltd.32.27BMarket Cap+27.32%52-week change51.04P/E (Trailing)‪10.69%‬Profit Margin
- AAVXFOTCAbivax SA12.12BMarket Cap+44.91%52-week change-28.78P/E (Trailing)‪0.00%‬Profit Margin
- AKESFOTCAkeso Inc.10.59BMarket Cap-91.48%52-week change25.67P/E (Trailing)‪-36.41%‬Profit Margin
- AKBLFOTCALK-Abelló A/S8.40BMarket Cap+23.64%52-week change39.91P/E (Trailing)‪19.85%‬Profit Margin
- BCHMYOTCBachem Holding AG7.09BMarket Cap+15.45%52-week change37.80P/E (Trailing)‪21.02%‬Profit Margin
Profile Summary - CMVLF - Cellectis S.A.
About
Cellectis S.A. is a clinical-stage biopharmaceutical company specializing in the development of next-generation immunotherapies for cancer. With over 25 years of innovation, Cellectis leverages its proprietary TALEN® gene-editing technology to engineer chimeric antigen receptor (CAR) T-cells, creating "off-the-shelf"…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
